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In Drosophila meianogaster, the Polycomb'group {PcG) genes have been identified as repressors of gene 
expression. They arc part of a ccllular memory system that is responsible for the stable transmission of gene 
activity to progeny cells. PcG proteins form a large multimeric, chromatin-associated protein complex, but the 
identity of its components is largely unknown. Here, we identify two human proteins, HPH1 and HPH2, that 
are associated with the vertebrate PcG protein BMI1. HPII1 and IIPH2 coimmunoprecipitate and cofraction- 
ate with each other and with BMI1. They also colocalize with BMI1 in interphase nuclei of U-2 OS human 
osteosarcoma and SW480 human colorectal adenocarcinoma cells. HPH1 and HPH2 have little sequence 
homology with each other, except in two highly conserved domains, designated homology domains I and II. 
They share these homology domains I and II with the Drosophila PcG protein Polyhomeotic (Ph), and we, 
therefore, have named the novel proteins HPH1 and HPH2. HPH1, HPH2, and BMI1 show distinct, although 
overlapping expression patterns in different tissues and cell lines. Two-hybrid analysis shows that homology 
domain II of HPH1 interacts with both homology domains I and II of HPH2. In contrast, homology domain I 
of HPH1 interacts only with homology domain II of IIPH2, but not with homology domain I of HPH2. 
Furthermore, BMI1 does not interact with the individual homology domains. Instead, both intact homology 
domains I and II need to be present for interactions with BMI1. These data demonstrate the involvement of 
homology domains I and II in protein-protein interactions and indicate that HPH1 and HPH2 are able to 
hetcrodimerize.
In Drosophila meianogaster, the genes of the Poly comb group 
(PcG) and irithorax group (t n G ) are part of a cellular memory 
system that is responsible for the stable inheritance of gene 
activity. The PcG and t?xG genes have been identified in Dro­
sophila as repressors (PcG) (17, 22, 30) and activators (trxG) 
(16) of homeotic gene activity. In PcG mutants, the expression 
patterns of homeotic genes are initially normal, but in later 
embryonic phases, homeotic genes become expressed in re­
gions of the embryo where they normally are repressed (22, 
29). Besides Polycomb (Pc), an estimated 30 to 40 mutants 
exhibit similar, characteristic posterior homeotic transforma­
tions. These are collectively referred to as Polycomb group 
(PcG) mutants (15), The Pc protein binds to about 100 loci on 
polytene chromosomes in the Drosophila salivary gland (37). 
Also the PcG proteins Polyhomeotic (Ph), Polycomblike (Pci) 
and Posterior sex combs (Psc) share many, but not all of these 
binding sites with Pc (10, 13, IS, 25). This is consistent with the 
idea that PcG proteins work together in a multimeric protein 
complex. Direct evidence that Pc is part of a multi meric com­
plex comes from experiments which showed that the PcG pro­
tein Ph coimmunoprecipitates with Pc (13).
An important clue about the molecular mechanism under­
lying PcG action is the observation that the Pc proteiii shares
* Corresponding auLhor. Mailing address: E. C. Slater Institute, 
University of Amsterdam, Plantagc Muidergracht 12, 1018 TV Am­
sterdam, The Netherlands. Phone: 31-20-5255115. Fax: 31-20-5255124. 
E-mail: arie.otte(&chem.uva.nI.
a homologous domain with the Drosophila heterochromatin- 
binding protein HP1 (23). This discovery provides an impor­
tant, direct link between regulation of gene activity and chro­
matin structure. It suggests that Pc and HP1 operate through 
common mechanisms, which may involve the formation of 
heterochromatin-like structures. This is further suggested by 
the finding that Pc is associated with chromatin over stretches 
of many kilobases. Pc specifically covers the silent part of the 
homeotic bithorax complex, which indicates that Pc represses 
gene activity by heterochromatinization (21).
PcG genes have originally been identified in Drosophila, but 
mammalian homologs of PcG genes have been identified re­
cently. A mouse Pc homolog, M33 (24), and a Xenopus Pc 
homolog, XPc (26), have been characterized. Another PcG 
gene, Posterior sex combs (Psc), possesses significant sequence 
homology to the murine oncogene Bmil (6, 34, 35). Targeted 
deletion of Bmil  results in a posterior transformation of the 
embryo and an anterior shift in the expression of homeotic 
genes (32,33). Vice versa, overexpression at Bmil  results in an 
anterior transformation and a posterior shift in the expression 
pattern of the homeotic gene Hoxc-5 (3). Also, targeted dele­
tion of mel-18, a closely related Bmil homolog, results in a 
posterior transformation of the embryo and an anterior shift in 
the expression of homeotic genes (1). Collectively, these data 
show that, also in vertebrates, PcG proteins are involved in the 
regulation of homeotic genes.
Considering the many novel features of regulation of gene 
activity by changes in chromatin structure, amazingly little is 
known about the molecular nature of chromatin structure. In
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particu lar, the composition of the chromatin-associated PcG 
com plex  is largely unknown. In order to characterize the mo­
lecu la r  nature of the verbrate PcG protein complex, we em­
p loy ed  the  genetic two-hybrid system (7, 11, 12, 14). We 
sc reened  a human leukocyte cDNA library for proteins that 
in te rac t with the vertebrate PcG protein Bmil. We report the 
identification of two novel human proteins that are associated 
w ith  B M Il. The proteins have little sequence homology with 
e a c h  other, except in two conserved homology domains, I and 
I t ,  which they share with the Drosophila PcG protein Ph. Based 
o n  the sequence homologies with Ph, we named these proteins 
H P T Il  and HPH2. Two-hybrid analysis indicates that the ho­
mology domains are involved in protein-protein interactions 
a n d  that HPH'l and HPH2 are able to heterodimerize through 
th e  homology domains.
TABLE 1. p-Galactosidase activities of Xbmil, HPH1, and HPH2
interactions in the two-hybrid system
MATERIALS AND METHODS
Isolation of the HPJI1 and HPH2 genes. The full-length coding region of 
X B m i l  (26) was cloned into the pAS2 vector (II, 14) (Ciontech, Palo Alio, 
Calif .)  and used as “bait” to screen for interacting proteins in a two-hybrid screen
( 12 ). The pASl-XBmil  plasmid was cotransformed with a human leukocylc 
M atchm ak er  two-hybrid library (Clonlcch) into the yeast Y 190 strain. The trans­
fo rm ants  were plated on selective medium lacking the leucine, tryptophan, and 
histidine amino acids, but containing 30 mM 3-aminoiriazole (II, 14). Approx­
imately 1.6 X 10fi independent clones were obtained. Three hundred growing 
colonies were obtained, of which 16 were p-galaclosidasc positive. After DNA 
isolation and icscrcening, six colonies remained histidine and [S-galactosidase 
positive. These clones were further characterized. Two of these clones were 2,1 
kb in length and were named UP! 12 hasec! on its homologous domains with 
Drosophila Ph and Riw28 (20). A total of 1.2 kb of this clone was the 3' noncoding 
region. The coding region of HPH2 as well as the first 5' 1,000 bp of the coding 
reg ion  of Rae2S were used to scrcen a X.gtl0 human fetal brain cDNA library 
(C iontech). Filters were hybridized overnight at 50°C in 0.5x SSC (IX SSC is
0 .J 5  M N a G  plus 0.015 M sodium citrate), J0X Denhardt’s solution, 10% 
dextran sulfate, 0.1% sodium dodecyl sulfate, (SDS), 100 jig of denatured her­
r in g  sperm DNA per ml, and an [a-32P]ATP-labelcd probe (5 X 10s cpm/ml). 
A f te r  being washed two times for 60 min at 55QC in 0.5x SSC and 0.1% SDS, the 
filters were auloradiographed with intensifying screens for 2 days at -70°C. This 
Jed to the isolation of the HPH1 cDNA.
RNA analysis. Multitissue Northern blots containing approximately 2 (j.g of 
poly(A) * RNA per lane from different human tissues or human cell lines were 
ob ta ined  commercially (Ciontech). The U-2 OS cell line was not present on the 
com m ercial Northern blot. Poly(A) 1 RNA of U-2 OS was isolated and blotted, 
a n d  the expression patterns of HPH1, HPJ-J2, and BMIÎ were analyzed. To allow 
i\ comparison with the commercial Northern blot, we blotted poly(A)^ RNA of 
SW 480 cells, which is represented on the commercial blot, and all three genes arc 
strongly expressed in this cell line. The hlots were hybridized with [ot-3“P]dATP- 
labclled D N A  probes and the blots were autoradiographed with intensifying 
.screens a t — 70°C with X-ray films.
Production of the Rac28 (Mphl) and IIPH2 polyclonal rabbit antibodies. A 
fragm ent encompassing amino acids (aa) 413 to 760 of Rae28 (Mphl) was cloned 
in to  the expression vector pGEX2T (Pharmacia, Uppsala, Sweden) to produce a 
g lu ta th ione  5-transfcrase-Mphl fusion protein (4). This fragment encompasses 
a  portion of the protein that is virtually identical to the corresponding region of 
H P H 1, but which is absent from the I-IPH2 protein. The purified fusion protein 
w a s  used to immunize a rabbit, and the scrum was affinity purified with Affigcl 
(B io-Rad). A  fragment encompassing aa 137 to 370 of HPH2 was cloned into the 
expression vector pET-23c (Novagen, Madison, Wis.). This fragment encom­
passes homology domain I, but lacks homology domain II. In homology domain
1, this region shares homology with homology domain I of HPH1, but the 
remaining porLion of the protein has no homology with HPH1. Purified fusion 
proteins were injected into a rabbit. The serum was affinity purified with CNBr 
Scpharose (Pharmacia, Uppsala, Sweden) to which the antigen was coupled. The 
production of the monoclonal antibody specific for BMI1 will be described 
elsewhere (4).
Immunoprécipitation and Western blotting. One 175-cm2 flask with human 
U-2 OS osteosarcoma cells which were grown to confluence was lysed in a ELB 
lysis buffer (250 mM NaCI, 0.1% Nonidet P-40, 50 mM HEPES [N-2-hydroxy- 
ethylpiperaüine-A/'-2-ethanesulfonic acid; pH 7.0], 5 mM EDTA, containing 0.5 
m M  dithiothreitol, 1 mM phenyfmethyisulfonyl fluoride, and prolease inhibitors, 
including leupeptin and aprotinin). The cell lysate was sonicated three times with 
bursts of 15 s, The lysate was centrifuged at 14,000 x g at 4°C for 10 min, and the 
supernatan t (500 |xl) was aliquoted and stored at -70°C. Fifty microliters of the 
supernatan t was subsequently incubated with the indicated antibodies, for 4 h to 
overnight at 4°C. Goat anti-rabbit or goat anti-mouse immunoglobulin G (IgG) 
antibodies coupled to agarose beads (Sigma) and ELB buffer were added to 
enlarge the volume of the mixture to 300 jjlI. The mixture was incubated for 2 h
DNA-binding Activation domain Colony % Relative f3-
domain fusion (aa) fusion (aa) color" galactosidase activity
HPIT1 (722-1013) HPH2 (137-432) Blue 80
HPH1 (722-780) HPH2 (137-432) Blue 20
HP HI (722-780) HPH2 (104-190) White <1
HPH1 (722-780) HPH2 (328-432) Blue 20
HPH1 (925-1013) HPH2 (137-432) Blue 55
HPH1 (925-1013) HPH2 (104-190) Blue 30
HPH.1 (925-1013) HPH2 (328-432) Blue 30
Xbmil (1-328) HPH2 (137-432) Blue 100'’
Xbmil (1-328) HPH2 (104-190) White < 1
Xbmil (1-328) H PI-12 (328-432) White <1
Xbmil (1-328) HPH2 (137-375) White < 1
" White colonies were obtained on medium lacking both histidine and 3-ami- 
notriazole. Blue colonies were obtained on medium lacking histidine, but in the 
presence of 3-aminotriazole.
h The average p-galactosidase activity in a triplicate experiment was 49 U. This 
activity was set at 100%.
at 4°C, under continuous mixing. The mixture was centrifuged at 1,500 x g at 4°C 
for 1 min, washed with 1 ml of ice-cold ELB buffer without protease inhibitors, 
and centrifuged at 1,500 X g at 4°C for 1 min. This washing procedure was 
repeated five times. After beating and centrifugation to remove the agarose 
beads, the proteins were separated by SDS-polyacrylamide gel electrophoresis 
(PAGE) and transferred to nitrocellulose, Typically, 10 /j.1 of the SW480 cell 
extract was loaded as input, and 50 jjlI of the SW480 ccll extract was used for the 
immunoprécipitation. The blots were probed with a 1:5,000 dilution of afiinity- 
purified anti-Rae28/Mphl or HPH2 antibodies or 1:3 dilution of tissue culture 
serum of the anti-Bmil monoclonal antibody. The secondary alkaline phos­
phatase-conjugated goaf anti-rabbit or mouse IgG (H + L) antibodies (Jackson 
Immuno Research Laboratories) were diluted 1:10,000 and nitrobluc tetrazo- 
lium-5-bromo-4-chloro-3-indolylphosphate toluidinium (Boehringer) was used 
as substrate,
Sucrose gradient ultracentrifugation. One hundred microliters of the U-2 OS 
cell extract in ELB buffer was loaded on top of a 5 to 30% sucrose gradient (5 
ml) in ELB buffer. The gradient was centrifuged in a TST 54 (Kontron) rotor at 
50,000 rpm for 8 h at 4°C. The gradient was prepared, and fractions were 
collected with a Buchler Auto Dcnsi-Flow IfC, Fourteen 350-|jd Fractions were 
collected, and proteins were precipitated by addition of 700 |jul of ice-cold eth­
anol. The proteins were dissolved in SDS-PAGE loading buffer. The samples 
were split, and the proteins were separated on two SDS-PAGE gels and trans­
ferred to nitrocellulose. The upper halves of both blots were probed with anti- 
Rae28/Mphl antibody to dctect the approximately 120-kDn HPH1, and the 
lower halves were probed with, respectively, anti-HPH2 (54 kDa) or anli-BMIl 
(44 to 46 kDa) antibody.
Analysis of interacting protein domains with the two-hybrid system. Indicated 
fragments of the cDNAs encoding HPH1 and HPH2 were derived by PCR 
(Expand, Boehringer). The fragments were subcloncd into the pAS2 (GAL4- 
DNA binding domain [GAL4-BD]) or GAD 10 (GAL4 activation domain 
[GAL4-AD]) vector. The fragments were sequenced over their entire length. The 
resulting plasmids were cotransformed into the yeast Y190 strain. The transfor­
mants were plated on medium lacking the leucine, tryptophan, and histidine 
amino acids, with or without 30 mM 3-aminotriazole. Interactions that were 
scored negative failed to grow in the presence of 30 mM 3-aminotriazolc. Be­
cause of residual ITIS3 promoter activity, they are able, however, to grow on 
medium that docs not contain 3-aminotriazole (U, 14). Under these nonselcctive 
conditions, negative interactions were p-galactosidase negative, and the colony 
color was indicated as white (Table 1). Positive interactions meet the two criteria 
of growth in the presence of 30 mM 3-aminotriazole, and they are p-galactosi- 
dase positive. To quanLitatc the p-galactosidase activity, cultures of 2.5 ml were 
grown to an optical density at 600 nm of 1.0 to 1.2 in medium lacking the leucine, 
tryptophan, and histidine amino acids. No 3-aminotriazole was added in the case 
of negative intcractors to allow them to grow. Cells were permeabilized, and 
fü-galactosidase activity was measured as described previously ( 11, 14; technical 
instructions of Ciontech). Measurements were performed in triplicate, starting 
with three independent colonies. To exclude the possibility that the negative 
interactors did not produce cither one of the fusion proteins, we Western blotted 
equal amounts of protein and incubated the blots with monoclonal antibodies 
that specifically recognize the GAL4-BD or the GAL4-AD protein (Ciontech). 
All positive and negative intcractors expressed both GAL4-I3D fusions and the 
GAL4-AD fusions at approximately the same levels (data not shown).
Immunofluorescence staining of tissue culture cells. U-2 OS and SW480 cells 
were cultured and labelled as described recently (28). Labelling has been ana-
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FIG. 3. Predicted amino acid sequence of HPH2. The homology domains I 
and II are indicated in boldface and underlined. The isolated two-hybrid clone 
encompasses homology domains I and II, starting from aa 137, which is indicated 
by an arrow.
lyzed by confocal laser scanning microscopy, of which single optical sections are 
shown. The first two pictures of each row represent the two different detection 
channels of the dual image, whereas the third picturc in each row represent the 
false color overlay. For labelling, donkey anti-rabbit IgG coupled to Cy3 (Jackson 
ImmunoResearch Laboratories) and donkey anti-mouse IgG coupled to DTAF 
{5-([4,6-dichlorotriazin-2-yljamino)fluorescein; Jackson} were used.
Nucleotide sequence accession number. The sequences for HPH1 and HPH2 
have been deposited with GenBank under accession numbers U89277 and 
U89278, respectively.
RESULTS
Isolation and characterization of the human HPHl  and 
HPH2 genes. To identify genes encoding proteins that interact 
with or are part of the vertebrate PcG multimeric protein 
complex, we performed a genetic two-hybrid screen (7, 11, 12, 
14). As target protein, we chose the Xenopus homolog of the 
vertebrate PcG protein Bmil (2,3,26, 35). At the protein level, 
XBmil is 90% identical and 95% similar to mouse and human 
BMI1 (26). We screened a human two-hybrid cDNA library. 
The full-length coding region of XBm il  (26) was cloned into 
the pAS2 vector ( 11 , 14). The \>AS2-XBmil plasmid was co-
transformed with a human leukocyte Matchmaker two-hybrid 
library (Ciontech) into the yeast Y190 strain. The transfor­
mants were plated on selective medium lacking the histidine, 
leucine, and tryptophan amino acids and in the presence of 30 
mM 3-aminotriazol (11, 14). Of approximately 1.6 X 106 inde­
pendent clones, 300 colonies were His'h, of which 16 were also 
(3-galactosidase positive. After DNA isolation and retransfor­
mation, six colonies remained His+ (3-Gal+. These clones did 
not grow on His“ plates with 3-aminotriazol when cotrans­
formed with either the empty pAS2 vector or with fusion pro­
teins unrelated to the target protein.
Two of these clones were identical. They were 2.1 kb in 
length and contained a 900-bp coding region and a 1,200-bp 3' 
noncoding region. The predicted protein coincides with two 
highly homologous domains of the Rae28 protein (Fig. 1 and 
2). Rae28 (retinoic acid-activated Early-28) has been identified 
in a differential screen for genes which respond to retinoic acid 
(20). Employing a two-hybrid screen, with Bmil as the target 
protein, Rae28 has been identified as interacting with Bmil 
(4). Rae28 shares considerable homology with the Drosophila 
PcG protein Ph, particularly in two domains, designated ho­
mology domains I and II, that are, respectively, 29 and 67 
amino acids long (9, 10, 20 [compare Fig. 2]). Sequence anal­
ysis indicated that the clone we isolated encompasses these two 
homology domains (Fig. 1 and 2). Homology domain I is 90 
and 52% identical with homology domain I of Rae28 and Ph, 
respectively. Homology domain II is 79 and 56% identical with 
homology domain II of Rae28 and Ph, respectively (Fig. 2). 
Also, a Cys2-Cys2 zinc finger motif is conserved between the 
protein we isolated and the Rae28 and Ph proteins. Not only 
the structure of this zinc finger motif, but also its location 
between homology domains I and II is conserved (Fig. 2). 
Based on these homologies, we named the clone we isolated 
HPH2 . Following the same reasoning, Alkema et al. recently 
renamed Rae28 Mphl  (4).
The HPH2 clone starts at homology domain I, suggesting 
that we did not isolate the full-length clone, but only the 3' 
region of the gene, To isolate full-length cDNAs of HPH2, we 
screened a human fetal brain library. Initially we used the 
1,300-bp 3' noncoding region of HPH2 as probe, but isolated
HPHl
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FIG. 2. Predicted amino acid sequence of HPHL The sequence is aligned to the Rae28/Mphl, Ph, and HPH2 sequences. Identical amino acids arc shown. The 
conserved amino acids of the putative zinc finger domain arc shaded. Homology domains I and II are boxed.
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no cDNAs which contained additional 5' sequences. We then 
used the coding sequences of HPH2 as probe, as well as the 
most upstream 5' 1,000 bp of the coding region of Rcie28!Mphl. 
We isolated a cDNA clone that overlapped with the HPH2 
two-hybrid clone, extending HPH2 with 140 aa (Fig. 1) and the 
HPH2 cDNA to 2,554 bp. The length of the HPH2 transcript 
and the molecular mass of HPH2 (see below) suggest that we 
isolated the full-length HPH2 cDNA.
Besides isolation of the extended HPH2  clone, we also iso­
lated two overlapping cDNA clones which are, in contrast with 
HPH2 , highly homologous with Rae28/Mphl (Fig. 2). The pre­
dicted 1,012-aa long protein is 95% identical with Rae28/Mphl 
and is only homologous with HPH2 and Ph in homology do­
mains I and II and the Cys2-Cys2 zinc finger (Fig. 2). Besides 
these sequence homologies, the protein shares a glutamine- 
rich stretch (aa 400 to 450) with Ph (Fig, 2 [9, 10, 20]). Given 
the high degree of homology with Ph, but also with the earlier 
characterized Rae28/Mphl, we named this clone HPHL
Homology domain II is also shared with other proteins. The 
products of the recently identified PcG gene, Sex comb on 
midleg (Scm) and of the Drosophila gene lethal(3)malignant 
brain tumor (l(3)mbt) share homology domain II (referred to as 
the SPM domain) with Ph, HPHl, and HPH2 (5,36). The SPM 
domain in the Scm protein is essential for its function (5). The 
occurrence of this domain in these diverse proteins suggests 
the existence of a family of proteins containing these homology 
domains.
In conclusion, a two-hybrid screen with the Xenopus ho­
molog of the vertebrate PcG protein Bmil as the target re­
sulted in the isolation of a human cDNA which encodes a 
protein that shares two homology domains with Rae28/Mphl 
and the PcG protein Ph. Subsequent screening of a cDNA 
library to isolate full-length clones of this cDNA led to the 
isolation of a second cDNA which is the human homolog of 
Rae28/Mphl. We named the proteins H PH l and HPH2. The 
longer H PH l protein is the virtually identical human homolog 
of Rae28/M phl. The shorter HPH2 protein which was isolated 
in the two-hybrid screen shares the homology domains, but 
further it has only limited homology with HPHl,
Distribution of HPHl and HPH2 transcripts in human tis­
sues and cancer cell lines. Besides limited sequence homology 
outside the homology domains, the HPH2  cDNA clone is con­
siderably shorter (2.55 kb) than the H P H l  and Rae28IMphl 
cDNA clones (3.2 and 3.5 kb, respectively [20]). To verify this 
difference in length at the level of mRNA transcripts, we char­
acterized the expression levels of the H P H l  and HPH2 genes. 
We analyzed multiple tissue Northern blots containing 
poly(A)H' mRNA from different human tissues or human cell 
lines (Ciontech). As probes, we selected the 5' coding region 
from the HPHl cDNA, since this region is not present in the 
HPH2  cDNA (Fig. 2) and the 3' noncoding region from the 
HPH2  cDNA.
We detected approximately 4.4- and 6-kb transcripts for the 
H P H l  gene and a single approximately 2,5-kb transcript for the 
HPH2  gene (Fig. 3 and 4). The length of the transcripts con­
firms that HPHl and HPH2 are different genes, The highest 
level of expression of HPHl is found in thymus (lane 2), testis 
(lane 4), and ovary (lane 5) (Fig. 3). Low expression levels were 
detected in spleen (lane 1), prostate (lane 3), small intestine 
(lane 6), colon (lane 7), and peripheral blood leukocytes (lane 
8). In contrast, HPH2, like BMI1, was expressed ubiquitously 
(Fig. 3).
The differences in the abundance of H P H l , HPH2, and 
BM11 transcripts are more pronounced in human cell lines 
than in normal human tissues (Fig. 4). The HPHl gene was 
strongly expressed in the Burkitt’s lymphoma Raji (lane 5),
Kb
7.5-
4.4- HPH1
2.4-
4 .4 -
2.4-
HPH2
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FIG. 3. Expression patterns o f  HPHl , HPH2, and DMU in human tissues. 
Shown arc expression levels in spleen (lane 1), thymus (lane 2), proslate (lane 3), 
testis (lane 4), ovary (lane 5), small intestine (lane 6), colon (lane 7), and 
peripheral blood leukocytcvs (lane 8). As probes, we selected the full-length BMH 
cDNA, the 5' coding region from the HPHl cDNA, since this region is not 
present in the HPH2 cDNA, and the 3' noncoding region from the HPHl cDNA. 
The iilter was rchybridized with a probe for GAPDH to verify the loading of 
RNA in each lane,
colorectal adenocarcinoma SW480 (lane 6), melanoma G381 
(lane 8), and U-2 OS osteosarcoma (lane 10) cell lines and at 
a much lower level in the other cell lines (Fig. 4). In contrast, 
both HPH2 and BMI1 were expressed at a low level in Burkitt’s 
lymphoma Raji cells. As in normal human tissues, no major 
differences in expression levels of HPH2 were observed, except 
in Burkitt’s lymphoma Raji cells (lane 5). An aberrant HPH2 
transcript was detected, specifically in the colorectal adenocar­
cinoma SW480 (lane 6). This approximately 5.5-kb transcript is 
expressed at a much lower level than the 2.5-kb transcript. No 
aberrant transcripts were detected in the mRNA from the 
other cell lines, not even after longer exposures. BMI1 expres­
sion is more varied than HPH2 expression, BMI1 being most 
strongly expressed in the K-562 (lane 3), SW480 (lanes 6 and 
9), and U-2 OS (lane 10) cell lines.
In summary, the H P H l , HPH2 and BMI1 genes are differ- 
entially expressed in normal human tissues and cancer cell 
lines. The length of the H P H l  and HPH2 transcripts confirms 
the existence of two different genes and also verifies that the 
HPH2 cDNA is considerably shorter than the HPHl cDNA.
HPHl and HPH2 coimmunoprecipitate with BMIL In order 
to test whether H P H l, HPH2, and BMI1 exist in vivo as part 
of a common protein complex, we performed immunoprécipi­
tation experiments with antibodies raised against the Rae28/ 
M phl, HPH2, and Bmil proteins. The predicted molecular 
mass of Rae28/MPhl, which is virtually identical to that of
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FIG. 4. Expression patterns of HPHl, HPH2, and #A-/7/ in human ccll lines. 
Shown ¡ire expression levels in the promyelocytic leukemia HL-60 (lane 1), HeLa 
S3 (lane 2), chronic myelogenous leukemia K.-562 (lane 3), lymphoblastic leu­
kemia MOLT-4 (lane 4), Burkitt’s lymphoma Raji (lane 5), colorectal adenocar­
cinoma SW480 (lane 6), lung carcinoma A549 (lane 7), and melanoma G361 
(lane 8) cell lines. The same probes as in Fig. 3 were used. Lanes 1 to 8 represent 
a commercially obtained Northern blot. We also isolated and blotted poly (A )+ 
RNA from U-2 OS (lane 10). To allow comparison with the commercial multiple 
tissue Northern blot, we isolated and blotted poly(A)'f' RNA from SW48U cells. 
Note that although the levels of expression of HPH2 and BMU  in SW480 are 
comparable, the level of expression of HPHl in SW480 cells is substantially lower 
in our hands (compare lanes 6 and 9).
H PH l, is 108 kDa. On Western blots, the affinity-purified 
antibody recognizes a protein with a size of approximately 120 
kDa (Fig. 5A). However, when a lower-percentage gel is used, 
it becomes apparent that H PH l runs as a doublet protein (Fig. 
5D). It is possible that the H P H l protein doublet is a reflection 
of the two, 4.4- and 6-kb HPHl  transcripts (Fig. 3 and 4). It is, 
however, also possible that the H PH l protein doublet arises 
from posttranslational modifications.
The highest expression levels of the H P H l , HPH2 , and BMI1 
genes are found in the SW480 and U-2 OS cell lines (Fig. 4). 
We used extracts of U-2 OS human osteosarcoma cells to 
perform coimmunoprecipitation experiments. Extracts of U-2 
OS cells were incubated with a mouse anti-Bmil antibody and 
subsequently with agarose-coupled goat anti-mouse IgG anti­
bodies. This monoclonal antibody is raised against murine 
Bmil protein and recognizes the human BMI1 protein (2). The 
resulting immunoprecipitate was Western blotted and incu­
bated with rabbit anti-Rae28/Mphl antibody. The 120-kDa 
H PH l protein was detected in the BMII immunoprecipitate 
(Fig. 5A, BM11 IP). The predicted molecular mass of HPH2, 
based on amino acid composition, is 47 kDa. On Western blots, 
the affinity-purified antibody recognizes a single 54-kDa pro­
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FIG. 5. Coimmunoprecipitation of HPHl and HPH2 with BMI1 from hu­
man U-2 OS osteosarcoma cells. (A) Extracts of U-2 OS human osteosarcoma 
cells were incubated with a mouse anti-Bmil antibody and subsequently with 
agarose-coupled goat anti-mouse IgG antibodies. The resulting IP was Western 
blotted and incubated with rabbit anti-Rae28/Mphl antibody. The approximately 
120-kDa HPHl protein (Input) was detected in the BMII BM11 IP. In this 
particular experiment, HPHl runs as a single protein, but when a lower percent­
age of polyacrylamide is used, the HPHl protein runs as a doublet (compare with 
panel D). When the Bmil antibody was omitted, no HPHl protein was detected 
(Mock IP), (B) The mouse anti-Bmil antibody immunoprecipitatcd the approx­
imately 54-kDa HPH2 protein (Input) from extracts of U-2 OS cells (BMII IP), 
No HPH2 protein was detected when the Bmil antibody was omitted from the 
immunoprécipitation (Mock IP). (C) The HPHl (HPHl IP) and HPH2 (HPH2 
IP) antibodies immunoprecipitated the approximately 44- and 46-kDa BMII 
proteins (Input) from extracts of U-2 OS cells. No BMII protein was detected 
when the HPH antibodies were omitted from the immunoprécipitation (Mock 
IP). (D) The HPH2 antibody immunoprccipitatcd the approximately 120-kDa 
HPHl protein (Input) from extracts of U-2 OS cells (HPH2 IP). No HPHl 
protein was detected when another, unrelated antibody was used in the immu­
noprécipitation (Mock IP). Note the rabbit heavy chain (Fc) in the HPH2 and 
mock IP.
tein (Fig. 5B, Input). The mouse anti-Bmil antibody was able 
to immunoprecipitate the HPH2 protein from extracts of U-2 
OS cells (Fig. 5B, BMII IP). The BMII immunoprécipitations 
were specific since no H P H l or HPH2 proteins were detected 
when the BMII antibody was omitted from the immunopré­
cipitations (Fig. 5A and B, Mock IP). Also when the unrelated 
mouse monoclonal antibody 5E10, which recognizes the PML 
protein (31), was used in the immunoprécipitation, no HPHl 
or HPH2 protein was detected (data not shown), underlining 
the specificity of the immunoprécipitation of HPHl and HPH2 
by the BMII antibody.
The predicted molecular mass of human BMII, based on 
amino acid composition, is 38 kDa (2). On Western blots, the 
antibody recognizes a doublet of 44- and 46-kDa proteins (Fig. 
5C, Input). Both the Rae28/Mphl and HPH2 antibodies were 
able to immunoprecipitate the BMII protein from extracts of 
U-2 OS cells (Fig. 5C, H P H l IP and HPH2 IP, respectively). 
No BMII was detected when the antibodies were omitted (Fig. 
5C, Mock IP) or when an unrelated antibody was added to the 
immunoprécipitations.
These results suggest that in vivo, HPHl and HPH2 are part 
of a protein complex which contains BMIL We further 
strengthened this notion by showing that the FIPH2 antibody 
was able to immunoprecipitate the HPHl protein from ex­
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tracts of U-2 OS cells (Fig. 5D, HPH2 IP). The HPH2 immu­
noprécipitations were specific, since no H PH l proteins were 
detected when an unrelated antibody was added to the immu­
noprécipitations (Fig. 5D, Mock IP). We also tried to immu­
noprecipitate HPH2 by using the Rae2S/Mphl antibodies. 
Since both Rae28/Mphl and HPH2 antibodies are rabbit de­
rived, the heavy chains (Fc) of the rabbit anti-HPH2 antibodies 
(Fig. 5D, Mock IP and HPH2 IP) or the rabbit anti-Rae28/ 
M phl are detected by the goat-anti rabbit alkaline-phospha- 
tase-conjugated antibody. Unfortunately, HPH2 migrates at 
th e  same position of these Fc heavy chains (compare Fig. 5B 
an d  D), thus preventing detection of HPH2 in IPs by the 
Rae28/Mphl antibodies.
The major part of the im mu noprecipitated or coimmuno- 
precipitated HPHl, HPH2, and BMII proteins was present in 
th e  pellet, indicating that the proteins indeed coimmunopre- 
cipitated. We could, however, still detect residual amounts of 
B M II, HPHl, or HPH2 proteins in the supernatants after 
immunoprécipitation with the BMII, Rae-28/Mphl, or HPH2 
antibodies (data not shown). Therefore, neither the immuno­
précipitation nor the coimmunoprecipitation can be consid­
ered  quantitative. However, since the majority of the proteins 
w ere  removed from the supernatants and present in the pellets, 
th is  indicates that HPHl, HPH2, and BMII proteins coimmu- 
noprecipitate from extracts of U-2 OS cells. This suggests that 
in  vivo, the proteins are part of a common protein complex.
H PH l, HPH2, and BMII cofractionate in a sucrose gradi­
ent» The coimmunoprecipitation experiments suggest that 
H P H l ,  HPH2, and BMII may be part of a high-molecular- 
mass protein complex. To test this idea, we performed velocity 
gradient ultracentrifugation experiments. We loaded extracts 
o f  U-2 OS cells, which had been prepared as in the immuno­
précipitation experiments, on a 5 to 30% sucrose gradient (5 
ml). After centrifugation 14 350-jxl fractions were collected. 
W e  calibrated the lower-molecular-mass range of the gradient 
with catalase (232 kDa) and thyroglobulin (669 kDa), which 
w ere  detected in fractions 1 and 3, respectively (Fig. 6). Lack of 
suitable markers prevented calibration of the higher-molecu- 
lar-mass range of the gradient. The proteins in the 14 fractions 
o f  the gradient on which the U-2 OS cell extract was loaded 
w ere separated by SDS-PAGE, blotted on nitrocellulose, and 
probed with antibodies against HPHl, HPH2, and BMI1. We 
found that the largest portion of the HPHl, HPH2, and BMII 
proteins cofractionate in fractions 7 through 11 (Fig. 6). This 
result indicates that the HPHl, HPH2, and BMII proteins are 
present in a complex with a molecular mass higher than 669 
kDa.
These results are in agreement with earlier results that dem­
onstrated that the Drosophila Polycomb and Polyhomeotic pro­
teins cofractionate by gel filtration and velocity gradient ultra­
centrifugation (13). We used a gradient ranging from 5 to 30% 
sucrose, which we found to result in a better separation than 
when the reported 5 to 20% gradient was used (13). Similar to 
w hat has been reported previously (13), we found a portion of 
the  HPPI1 and BMII proteins to be present in the pellet of the 
gradient (Fig. 6, fraction 14). We also found a substantial 
portion of the HPHl and BMII proteins to be present in 
fraction 1 (Fig. 6). In contrast, no HPH2 protein was detected 
in  either fraction 1 or fraction 14. The meaning of these ob­
servations is unclear. It has been speculated that the presence 
o f  the proteins in the lower-molecular-mass range of the gra­
dient can be explained by partial dissociation of the complex 
during the preparation (13). Alternatively, it could indicate a 
heterogeneous composition of the multimeric complex (13). At 
present, it is not clear which is the right interpretation. The 
presence of the HPHl, PIPPI2, and BMII proteins in fractions
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FIG. 6. Cofractionation of HPHl, HPII2, unci BMII from human U-2 OS 
osleosarcoma cells. Cell extract was loaded on a 5 to 30% sucrose gradient, and 
the gradient was centrifuged in a TST50 (Kontron) rotor at 50,000 rpm for 8 h. 
Fourteen 350-|xl fractions (indicated on top) were collected, and proteins were 
precipitated and separated on two SDS-PAGE gels and transferred to nitrocel­
lulose. The upper halves of both blots were probed with anti-Rae28/Mph I an­
tibody to deLect the approximately 120-kDa HPHl, and the lower halves were 
probed with, respectively, anti-HPH2 (54-kDa) (middle panel) or anti-BMI 1 (44- 
to 46-kDa) (lowest panel) antibody. This procedure was followed since the 
similar molecular mass ranges of HPH2 and BMII excluded the possibility ol‘ 
detecting all Ihrce proteins on a single blot. By using a separate 5 to 30% 
gradient we calibrated the lower-molecular-mass range of the gradient by using 
catalase (232 kDa) and thyroglobulin (669 kDa) (Pharmacia, Uppsala, Sweden) 
as markers. The fractions in which the markers were detected are indicated by 
arrows, The fractions containing a higher percentage sucrose were not calibrated 
because of a lack of suitable markers.
7 through 11, however, supports the idea that the proteins are 
part of a common, multimeric protein complex.
H P H l and HPII2 colocalize with BMII in nuclei of U-2 OS 
and SW480 cells. We next analyzed the subcellular localization 
of the H PH l and FIPH2 proteins in relation to the PcG protein 
BMII by performing immunofluorescence labelling experi­
ments. The use of mouse anti-Bmil and rabbit anti-Rae287 
Mphl and HPH2 allows double-labelling experiments. We 
used U-2 OS human osteosarcoma cells and SW480 human 
colorectal adenocarcinoma cells, in which we found that 
H P H l , HPH2, and BMII are all expressed at a high level (Fig. 
4). In extracts of U-2 OS cells, we found that HPHl and HPH2 
coimmunoprecipitate and cofractionate with each other and 
with BMII (Fig. 5 and 6). In U-2 OS cells, both H P H l and 
BMII are found in the nucleus and throughout the nucleo­
plasm, and they colocalize in large, brightly labelled domains 
(Fig. 7A to C). Also HPH2 and BMII colocalize in the same 
brightly labelled domains (Fig. 7D to F). H PHl and HPH 2 
colocalize with BMII in the large domains, but as yet, this is 
not clear for the more homogeneously distributed pattern. The 
fine granular pattern is too complex to allow analysis of any 
systematic colocalization.
The observed labelling patterns of HPHl, HPH2, and B M I1 
are in contrast with recently published labelling patterns of the 
Bmil protein (8). It should be pointed out, however, that these 
workers detected overexpressed Bmil protein in R a ti  fibro­
blasts or COS cells in which no endogenous Bmil could be 
detected (8). We, on the other hand, detcctecl endogenous 
levels of BMII in cell lines which express the BM II  gene at a 
high level (Fig. 4). This is a likely explanation for the observed 
differences in labelling patterns. The significance of the do-
2332 GUNSTER ET AL. M o l . C e l l . B io l .
A
<> '  s
• i
* «fc-st# : <# « w
«g
i r ...
s
» .
$x»
«i
Vi,
il.
f i
«
*
* r<.s ^ V  *
FIG. 7. Colocalization of HPHl and HPH2 with BMII in nuclei of U-2 OS cells. (A to C) Rabbit anti-Rae28/Mphl (A) and mouse anti-BMIl (B) labelling is shown 
in single confocal optical sections. Panels A and B represent the two different detection channels of the dual image, whereas panel C represents the false color overlay. 
HPHl and BMII are homogeneously distributed in the nucleus, but are also concentrated in large, brightly labelled domains. HPHl and BMII colocalize in these large 
domains (C) (indicated by yellow). With rabbit anti-HPH2 (D) and mouse anti-BMIl (E) antibodies, similar distribution patterns and colocalizations (F) were observed.
mains in which HPHl, HPH2, and BMII colocalize is further 
underlined by our recent finding that a human homolog of the 
Polycomb protein also colocalizes with BMII in these domains 
(27). This human Pc homolog also coimmunoprecipitates with
BMII (27).
We further analyzed the subcellular localization of HPHl 
and HPH2 in relation to BMII in SW480 cells. As in U-2 OS 
cells, we found complete colocalization between HPHl (Fig.
8A to C) and HPH2 (Fig. 8D to F) and BMII in large, brightly 
labelled domains. These results demonstrate that the colocal­
ization of HPHl and HPH2 with the PcG protein BMII is not 
restricted to one cell type.
We conclude that HPHl and HPH2 colocalize with BMII in 
large domains in the nuclei of U-2 OS and SW480 cells. These 
results further underline the validity of the identified two- 
hybrid interaction between HPH2 and BMIL They strengthen 
the notion that HPHl, HPH2, and BMII are part of a multi-
meric protein complex.
Interactions between homology domains I and II of HPHl 
and HPH2. We found that HPH2 is able to immunoprecipitate
HPHl (Fig. 5D), that HPHl and HPH2 cofractionate in a domains I and II need to be present in the fusion protein (Fig.
domain and it has been suggested that this domain is involved 
in protein-protein interactions (5). By using the two-hybrid 
assay, we therefore tested whether the homology domains of 
HPHl and HPH2 can mediate protein-protein interactions. 
The region encompassing homology domains I and II from 
HPHl (aa 722 to 1013 [Fig. 9A]) was fused to the GAL4 DNA 
binding domain. The plasmid was cotransformed with the 
HPH2 two-hybrid clone, encompassing homology domains I 
and II (aa 137 to 432 [Fig. 9A]) (see Fig. 1). The transformants 
were able to grow on selective medium lacking histidine, in the 
presence of 3-aminotriazole, and were also p-galactosidase 
positive. This result indicates an interaction between homology 
domains I and II of HPHl and HPH2, and we subsequently 
tested potential interactions between the individual homology 
domains. We found that homology domain I of HPHl interacts 
with homology domain II, but not with homology domain I of 
HPH2. Also, homology domain II of HPHl interacts with both 
homology domains I and II of HPH2 (Fig. 9A). In contrast, 
BMII does not interact with individual homology domains I 
and II. For an interaction with BMII, both intact homology
sucrose gradient (Fig. 6), and that HPHl and HPH2 colocalize 
with BMII in the nuclei of interphase cells (Fig. 7 and 8).
9B).
To quantify the strength of the interactions between the 
These results suggest that HPHl and HPH2 are part of a different portions of the HPHl and HPH2 proteins, we pre­
common protein complex, but they do not address the question pared lysates of the transformants and measured the (3-galac- 
of whether HPHl and HPH2 interact with each other. Homol- tosidase activity. The interaction between Xbmil and HPH2 
ogy domains I and II are potentially involved in protein-pro- (aa 137 to 375), which was identified in our original two-hybrid
tein interactions. Significant homology has been found be- screen (Fig. 1), was found to be the strongest. The relative
tween the Rae28/Mphl and Ph homology domain II and the strengths of the other interactions are given as percentage of 
recently characterized protein encoded by the PcG gene Sex the Xbmil-HPH2 (aa 137 to 375) interaction (Table 1). The 
comb on midleg (Scm) (5). This domain has been named SPM second strongest interaction was found between HPHl (aa 722
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. 8. Colocalization of H P H l and HPH2 with BMII in nuclei o f  SW 480 cells. (A  to C) R; inti-R (A) and mouse anti-BMIl (B) labelling and the
overlay (C) are shown. Similar to in U-2 OS cells (Fig. 7), H P H l and BMII colocalizc in large, brightly labelled domains (C) (indicated by yellow). With
anti-HPH2 (D) and mouse anti-BMIl (E) antibodies, similar distribution patterns and * r oe
to 1013) and HPH2 (aa 137 to 432), in which both 
homology domains of HPHl and HPH2 were present. When 
single homology domains were tested against each other, a
decrease in the strength of the interactions was observed (Ta­
ble 1).
Taken together, these results demonstrate the importance of 
the homology domains in protein-protein interactions, 
further suggest that HPHl and HPH2 can heterodimerize in 
vivo through these homology domains.
DISCUSSION
Are HPHl, HPH2, and the PcG protein BMII part of a 
multimene protein complex? It has been proposed that PcG 
proteins repress homeotic gene expression via the formation of 
multimeric complexes. This model is based on the observation 
that different PcG proteins bind in overlapping patterns to 
about 100 loci on poly tene chromosomes in 
salivary gland (10, 13, 18, 25, 37). However,
PcG protein Polyhomeotic, but no other known proteins, has 
been shown to coimmunoprecipitate or cofractionate with Pc
Employing the genetic two-hybrid system, we identified a 
protein that specifically interacts with the vertebrate PcG pro­
tein BMII. Based on the occurrence of two conserved homol­
ogy domains that are shared with Ph and the vertebrate Rae28/ 
Mphl protein, we name this protein HPH2 (see below). We 
also identified the human homolog of the protein expressed by 
the Rae28/Mphl gene, which we name HPHl. Our results 
indicate that mammals have at least two proteins that bear 
similarity to the Drosophila Ph protein. The homology domains 
appear to be involved in mediating interactions between H PH l
and HPH2 as well as between Xbmil and HPH2. We further 
show that HPHl and HPH2 coimmunoprecipitate with BMII 
and with each other, indicating an in vivo association between 
these proteins. This notion is further supported by our finding 
that HPHl, HPH2, and BMII cofractionate in a sucrose gra­
dient. Furthermore, HPHl, HPH2, and BMII colocalize in 
interphase nuclei of two different human lines. Together, these 
data provide evidence for an in vivo association and indicate 
that HPHl and HPH2 are part of a human multimeric protein 
complex which also contains the vertebrate PcG protein BMII.
In summary, four different approaches, namely (i) the two- 
hybrid assay, (ii) coimmunoprecipitation experiments, (iii) co- 
fractionation experiments, and (iv) immunocolocalization ex­
periments, all indicate that HPHl, HPH2, and BMII are part
a common, ic protein
Are HPHl and HPH2 homologs of the PcG protein Polyho-
meotic? Two lines of evidence suggest that HPHl and HPH2 
are functional homologs of the Drosophila PcG protein 
homeotic (Ph). In the first place, based on four different ap-
evidence for the notion that(see we
HPHl, HPH2, and BMII are part 
complex.
d
is a vertebrate PcG protein 
a functional vertebrate
PcG protein Posterior sex combs (6, 35). It is feasible that 
proteins that form a complex with PcG proteins are also PcG
. In the second place, the HPHl and HPH2 proteins 
share extensive sequence and overall structural homology with 
the Drosophila PcG protein Ph. Both HPHl and HPH2 share 
the conserved homology domains I and II with Ph. In addition, 
a particular Cys2-Cys2 zinc finger motif is conserved, both in 
terms of sequence homology and in terms of its position be­
tween the two homology domains. Also, a glutamine-rich re-
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+
FIG. 9. Interaction« between homology domains I and II (H-I and H-II, 
respectively) of HPHl and HPH2. (A) Indicated portions of H P H l were fused 
to the GAL4 DNA binding domain. These H PH l regions encompass homology 
domains I and II (aa 722 to 1013), homology domain I (aa 722 to 780), and 
homology domain II (aa 925 to 1013) alone. The plasmids were cotransformed 
with the originally isolated HPH2 two-hybrid clone (aa 137 to 432), which is 
fused to the GAL4 transactivation domain. Also, homology domain I (aa 104 to 
190) and homology domain II (aa 328 to 432) of HPH2 were tested against the 
indicated portions of HPHl. AJI interactions were positive (+), as judged by the 
ability of the transformants to grow on selective medium lacking histidine, and 
they were also (3-galactosidase positive. (B) Full-length Xbmil (aa 1 to 328), 
fused to the GAL4 DNA binding domain, was tested for interaction against 
indicated portions of HPH2, which are fused to the GAL4 transaclivation do­
main. The quantitative analysis of the interactions is represented in Table 1. 
Homology domain II has also been termed SPM (5).
gion is located in HPHl in the same region of the protein as in 
Ph, In this context, a similar situation with the murine Pc 
homolog M33 is very relevant. M33 shares only the conserved 
chromodomain (52 aa long) and C terminus (17 aa long) with 
Pc (24), but it is still able to partly rescue the Drosophila Pc 
phenotype, when overexpressed in the Pc mutant (19). Al­
though the homology is restricted to small regions and the 
overall composition of the protein, M33 can be considered to 
be a functional homolog of Pc.
Both lines of evidence are supportive for the idea that H PH l 
and HPH2 are human homologs of Ph. Although the sequence 
and structural homologies between Ph and Rae28 have been 
noted before (20), at that time it was unclear whether this 
implied that the Rae28 protein is a functional, mammalian 
homolog of the PcG protein Ph. We now show that the human 
Rae28 homolog, HPHl, as well as HPH2, interacts with and 
colocalizes with a noted member of the vertebrate PcG family, 
BMIL We are, therefore, tempted to conclude that we have 
identified components of a human PcG protein complex. It will 
be of considerable interest to test whether loss-of-function 
mutations of the mouse Rae28IMphl gene and the murine 
homolog of HPH2 result in homeotic transformations.
Possible functional significance of the existence of multiple 
HPH proteins. We have presented evidence that H PH l, 
HPH2, and BMII are part of a multimeric protein complex. 
Our data also indicate that homology domains I and II of 
H PHl and HPH2 are involved in mediating protein-protein 
interactions. These data suggest that H P H l and HPH2 are 
able to form heterodimers through their respective homology 
domains I and II. This may imply that their function is exerted 
via heterodimerization and that the human multimeric PcG 
complex requires the presence of both H P H l and HPH2.
The occurrence of two proteins with homology to Ph may
also point towards the interesting possibility of the existence of 
different mammalian multimeric PcG complexes. This idea is 
supported by the differential expression patterns of HPHL  
HPH2, and BMII  (Fig. 3 and 4). HPH2, like B M II , is expressed 
ubiquitously in all tissues and cell lines tested, whereas HPHl 
has a more limited expression pattern. Since we screened a 
peripheral blood leukocyte two-hybrid library, it is not amazing 
that we isolated HPH2 as a BMII binding protein. HPH2 is 
abundantly expressed in this tissue, and H P H l  is expressed 
only at a very low level. This might indicate that in leukocytes, 
HPH2 and BMII are components of the PcG complex and 
H P H l is not.
The idea that PcG complexes exist with different composi­
tions is reinforced by the observation that the PcG protein Psc 
shares many, but not all binding sites with the PcG proteins Pc, 
Ph, and Pci on salivary gland polytene chromosomes (10, 18, 
25, 37). Distinct compositions of the PcG complexes could lead 
to specificity in the repression of different loci in different 
tissues. This provides flexibility, and it increases the possibili­
ties of regulating a wide range of target genes with only a 
limited number of components.
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